rs139588879

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_017838.4(NHP2):​c.352G>A​(p.Ala118Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00073 in 1,613,520 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0033 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00047 ( 3 hom. )

Consequence

NHP2
NM_017838.4 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 6.08

Publications

4 publications found
Variant links:
Genes affected
NHP2 (HGNC:14377): (NHP2 ribonucleoprotein) This gene is a member of the H/ACA snoRNPs (small nucleolar ribonucleoproteins) gene family. snoRNPs are involved in various aspects of rRNA processing and modification and have been classified into two families: C/D and H/ACA. The H/ACA snoRNPs also include the DKC1, NOLA1 and NOLA3 proteins. These four H/ACA snoRNP proteins localize to the dense fibrillar components of nucleoli and to coiled (Cajal) bodies in the nucleus. Both 18S rRNA production and rRNA pseudouridylation are impaired if any one of the four proteins is depleted. The four H/ACA snoRNP proteins are also components of the telomerase complex. This gene encodes a protein related to Saccharomyces cerevisiae Nhp2p. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2008]
RMND5B (HGNC:26181): (required for meiotic nuclear division 5 homolog B) Predicted to enable metal ion binding activity and ubiquitin protein ligase activity. Predicted to contribute to ubiquitin-protein transferase activity. Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010230422).
BP6
Variant 5-178149823-C-T is Benign according to our data. Variant chr5-178149823-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416618.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHP2NM_017838.4 linkc.352G>A p.Ala118Thr missense_variant Exon 4 of 4 ENST00000274606.8 NP_060308.1 Q9NX24
RMND5BNM_022762.5 linkc.*1791C>T 3_prime_UTR_variant Exon 11 of 11 ENST00000313386.9 NP_073599.2 Q96G75-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHP2ENST00000274606.8 linkc.352G>A p.Ala118Thr missense_variant Exon 4 of 4 1 NM_017838.4 ENSP00000274606.4 Q9NX24
RMND5BENST00000313386.9 linkc.*1791C>T 3_prime_UTR_variant Exon 11 of 11 1 NM_022762.5 ENSP00000320623.4 Q96G75-1

Frequencies

GnomAD3 genomes
AF:
0.00327
AC:
497
AN:
152178
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0114
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00106
AC:
265
AN:
250778
AF XY:
0.000768
show subpopulations
Gnomad AFR exome
AF:
0.0124
Gnomad AMR exome
AF:
0.000928
Gnomad ASJ exome
AF:
0.00130
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.000656
GnomAD4 exome
AF:
0.000465
AC:
680
AN:
1461224
Hom.:
3
Cov.:
31
AF XY:
0.000395
AC XY:
287
AN XY:
726824
show subpopulations
African (AFR)
AF:
0.0126
AC:
422
AN:
33468
American (AMR)
AF:
0.00112
AC:
50
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
0.00111
AC:
29
AN:
26094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39678
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86162
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53406
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
0.000103
AC:
114
AN:
1111648
Other (OTH)
AF:
0.000861
AC:
52
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
34
69
103
138
172
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00327
AC:
498
AN:
152296
Hom.:
2
Cov.:
33
AF XY:
0.00295
AC XY:
220
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0114
AC:
474
AN:
41550
American (AMR)
AF:
0.000850
AC:
13
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68020
Other (OTH)
AF:
0.00142
AC:
3
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
23
46
69
92
115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00353
Hom.:
7
Bravo
AF:
0.00376
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00931
AC:
41
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00105
AC:
127
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 11, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 12, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Dyskeratosis congenita Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NHP2-related disorder Benign:1
Sep 27, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.54
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.37
CADD
Uncertain
23
DANN
Benign
0.95
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.13
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.84
T
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-1.0
T
PhyloP100
6.1
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-0.99
N
REVEL
Benign
0.062
Sift
Benign
0.61
T
Sift4G
Benign
0.30
T
Polyphen
0.018
B
Vest4
0.23
MVP
0.74
MPC
0.39
ClinPred
0.035
T
GERP RS
4.4
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.0
Varity_R
0.12
gMVP
0.51
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139588879; hg19: chr5-177576824; COSMIC: COSV51071283; COSMIC: COSV51071283; API